基于DNA分裂因子40的癌症治疗方法:一篇综述文章
Faezeh Masaeli1, Saba Omoomi1, Fatemeh Shafiee2,3
1Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Hezar Jarib Ave., Isfahan, Iran.
DNA碎片化因子 (DFF) 对于亡至关重要. 本综述探讨了低DFF40表达的癌症和治疗策略,包括重组蛋白和基因疗法,以增强癌细胞亡.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- DNA碎片化因子 (DFF) 是一种关键的蛋白质复合体,在亡期间调解DNA碎片化.
- DFF40是DFF的一个子单元,在染色体DNA分解中起着至关重要的作用.
- 改变DFF40表达与各种癌症有关,在某些类型中观察到下调.
研究的目的:
- 为了审查显示低DFF40表达的癌症.
- 研究使用外源DFF40蛋白的治疗策略.
- 讨论恢复DFF40表达和诱导癌细胞的亡的基因疗法方法.
主要方法:
- 对癌症中DFF40表达的研究进行文献综述.
- 在体外和体内使用复合DFF40蛋白的研究分析.
- 基因治疗技术的调查,旨在补偿降低的DFF40水平.
主要成果:
- 特定癌症的识别,其特征是DFF40表达减少.
- 证据支持外源DFF40在促进癌细胞亡中的有效性.
- 证明基因治疗有可能恢复DFF40功能并诱导亡.
结论:
- 低DFF40表达是某些癌症的特征,具有治疗点.
- 重组DFF40和基因疗法提供了通过增强亡来对抗癌症的有希望的策略.
- 对基于DFF40的治疗方法的进一步研究可能会导致新的癌症治疗方法.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
